E
IDYA icon

Ergoteles’s IDEAYA Biosciences IDYA Stock Holding History

Ergoteles’s Portfolio IDYA Stock Details IDYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-40,807
Closed -$959K – 419
2023
Q2 		$959K Buy
40,807
+28,076
+221% +$577K 0.05% 476
2023
Q1 		$175K Buy
+12,731
New +$212K 0.01% 1033
2022
Q1 		– Sell
-10,100
Closed -$239K – 1410
2021
Q4 		$239K Buy
+10,100
New +$235K 0.01% 949

Other funds holding IDYA

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CPX
Canaan Partners X Menlo Park, California $74.7M AUM 151.56% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Ergoteles's IDYA Position: Q3 2023 in Review

Ergoteles sold out of IDEAYA Biosciences (IDYA) in Q3 2023, closing a stake of 40,807 shares — an estimated $959K sold.

Ergoteles first reported a position in IDYA in Q4 2021 and held it in 3 quarters. The position peaked at $959K in Q2 2023. 144 funds tracked by Wall St. Rank hold IDYA as of Q3 2023.

  • Ergoteles reported no remaining IDEAYA Biosciences position as of Q3 2023 after selling out during the quarter.
  • Ergoteles sold 40,807 IDEAYA Biosciences shares in Q3 2023, an estimated $959K.
  • Ergoteles first reported a position in IDEAYA Biosciences in Q4 2021 and held it in 3 quarters.
  • Ergoteles's IDEAYA Biosciences position peaked at $959K in Q2 2023.
  • 144 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q3 2023.

Based on Ergoteles's 13F filing for Q3 2023, filed 14 Nov 2023.